Cognitive Functions on Coronary Surgery

Sponsor
Bursa Yüksek İhtisas Education and Research Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT04725708
Collaborator
(none)
100
1
2
9
11.1

Study Details

Study Description

Brief Summary

The aim of this study is to examine the effects of different but safe levels of arterial oxygen levels used in cardiac surgeries on cerebral oxygenation during the operation. It is also to investigate the effect on cognitive functions in the postoperative period. For our study the investigators will conduct a randomized control trial. Patients will be randomly assigned to one of two possible study groups according to the arterial oxygen levels.If there is any abnormality in cerebral oxygen levels during surgery, necessary intervention will be made by doctors.

Condition or Disease Intervention/Treatment Phase
  • Procedure: procedure: cerebral oxygenation intervention
N/A

Detailed Description

In most cardiovascular surgeries, patients are frequently followed up at hyperoxemic level for safety purposes against the risk of tissue hypoxia that may develop during surgery due to CPB use. At the level of hyperoxemia, there are opinions that the ischemia-reperfusion damage increases with the follow-up of CABG surgery, microcirculation is impaired and tissue oxygenation is impaired due to the resulting hyperoxemic vasoconstriction. Recent research has focused on evaluating optimal oxygen levels in CPB during cardiac surgery. However, the potential of tightly regulated intraoperative normoxia to improve POCD following cardiac surgery has not been studied prospectively.

The purpose of this study is to determine whether patients who underwent CPB and CABG, which were preserved under normoxic conditions during the intraoperative period, would have a lower incidence of early and late POCD than those exposed to hyperoxia.

Study Design

Study Type:
Interventional
Actual Enrollment :
100 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Prevention
Official Title:
The Effect of Intraoperative Arterial Oxygen Levels on Cognitive Functions After Coronary Bypass Graft Surgery
Actual Study Start Date :
Nov 1, 2019
Actual Primary Completion Date :
May 1, 2020
Actual Study Completion Date :
Aug 1, 2020

Arms and Interventions

Arm Intervention/Treatment
Experimental: normoxy

Group 1(n=50) FiO2%40, PaO2<180 ve PaO2≥80mmHg MMSE will be applied to patients before surgery. At the determined measurement times body and blood temperature, SpO2, HR, MAP, PH, blood gas lactate, blood gas base deficit, urine output, PaO2, PaCO2, Htc, FiO2, right and left rSO2 values were monitored. An rSO2 less than 45% triggered an alarm, the anesthesiologist timed the event, and after 60 seconds initiated an intervention protocol means; PaO2 levels were checked, PaO2> 100 mmHg was achieved, if not improved, pump blood flow, mean arterial pressure were increased, if there is still no response and hematocrit <20%, patients were scheduled for erythrocyte transfusion until the rSO2 was restored to at least 60% at both probes.In the postoperative period, at the 24th hour, when routine cardiological controls were performed 1., 3., 6. Simultaneous MMSE will be repeated in months.

Procedure: procedure: cerebral oxygenation intervention
During the surgery, cerebral oxygenation will be followed and intervention will be made to pH, PaO2, PaCO2, mean arterial pressure, hematocrit when necessary. In addition perfusion flow was maintained at or close to between 2.2-2.5 L/min/m2 . Perfusion pressure was adjusted using a phenylephrine infusion to maintain a mean arterial pressure of 50 to 70 mm Hg.

Experimental: hyperoxia

Group 2(n=50) FiO2%100, PaO2≥180mmHg MMSE will be applied to patients before surgery. At the determined measurement times body and blood temperature, SpO2, HR, MAP, PH, blood gas lactate, blood gas base deficit, urine output, PaO2, PaCO2, Htc, FiO2, right and left rSO2 values were monitored..In the postoperative period, at the 24th hour, when routine cardiological controls were performed 1., 3., 6. Simultaneous MMSE will be repeated in months.

Procedure: procedure: cerebral oxygenation intervention
During the surgery, cerebral oxygenation will be followed and intervention will be made to pH, PaO2, PaCO2, mean arterial pressure, hematocrit when necessary. In addition perfusion flow was maintained at or close to between 2.2-2.5 L/min/m2 . Perfusion pressure was adjusted using a phenylephrine infusion to maintain a mean arterial pressure of 50 to 70 mm Hg.

Outcome Measures

Primary Outcome Measures

  1. postoperative neurocognitive function [12 hours after surgery]

    Change on MMSE is important for neurocognitive disorder.The MMSE consists of cognitive functions of orientation, attention, calculation, memory and language.

  2. postoperative neurocognitive function [24 hours after surgery]

    Change on MMSE is important for neurocognitive disorder.The MMSE consists of cognitive functions of orientation, attention, calculation, memory and language.

  3. postoperative neurocognitive function [1 month after surgery]

    Change on MMSE is important for neurocognitive disorder.The MMSE consists of cognitive functions of orientation, attention, calculation, memory and language.

  4. postoperative neurocognitive function [3 months after surgery]

    Change on MMSE is important for neurocognitive disorder.The MMSE consists of cognitive functions of orientation, attention, calculation, memory and language.

  5. postoperative neurocognitive function [6 months after surgery]

    Change on MMSE is important for neurocognitive disorder.The MMSE consists of cognitive functions of orientation, attention, calculation, memory and language.

Secondary Outcome Measures

  1. Extubation time after surgery [During the hospitalization for postoperative recovery ,average 8 days]

    Weaning times from mechanical ventilation among patients who are followed up with the same intensive care approach after surgery

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 90 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • adult patients scheduled to undergo elective cardiopulmonary bypass graft surgery
Exclusion Criteria:
  • severe preoperative cognitive impairment(i.e. dementia, intellectual disorder)

  • Non-Turkish speaking patients

  • presence of end-stage organ failure

  • patients requiring emergency coronary surgery

  • surgical procedures requiring single lung ventilation

Contacts and Locations

Locations

Site City State Country Postal Code
1 Bursa YIERH Bursa Turkey 16200

Sponsors and Collaborators

  • Bursa Yüksek İhtisas Education and Research Hospital

Investigators

  • Principal Investigator: Tuğba T ONUR, MD, Bursa Yüksek İhtisas Education and Research Hospital
  • Study Chair: ANIL A ONUR, MD, Bursa Yüksek İhtisas Education and Research Hospital
  • Study Chair: Ümran U KARACA, MD, Bursa Yüksek İhtisas Education and Research Hospital
  • Study Chair: Halil Erkan H SAYAN, MD, Bursa Yüksek İhtisas Education and Research Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Tugba Onur, Principal investigator, Bursa Yüksek İhtisas Education and Research Hospital
ClinicalTrials.gov Identifier:
NCT04725708
Other Study ID Numbers:
  • Bursa YIERH
First Posted:
Jan 27, 2021
Last Update Posted:
Jan 27, 2021
Last Verified:
Jan 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Tugba Onur, Principal investigator, Bursa Yüksek İhtisas Education and Research Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 27, 2021